Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on metal free photoredox chemistry. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Solve explosive risks and metal residues in deuterated synthesis. Achieve 99% deuteration with no catalysts. Scale to 100 MT/annual for drug development.